# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5040290 | B | Inhibition of SARS-COV2 spike protein mediated infection of human ACE2 expressing cells | Severe acute respiratory syndrome coronavirus 2 | 4 | assay format | Scientific Literature | ||
2. | ALA5040291 | B | Binding affinity of SARS-COV2 S-RBD by BLI assay | Severe acute respiratory syndrome coronavirus 2 | 2 | single protein format | Scientific Literature | ||
3. | ALA5040292 | F | Antiviral activity against SARS-COV2 infected in Calu-3 cells incubated for 48 hrs by ELISA | Severe acute respiratory syndrome coronavirus 2 | 1 | organism-based format | Scientific Literature | ||
4. | ALA5040294 | F | Antiviral activity against SARS-COV2 infected in HT-1080 cells expressing ACE2 preincubated for 30 mins followed by cell addition after 24 hrs by Nano-glo luciferase reagent based assay | Severe acute respiratory syndrome coronavirus 2 | 1 | organism-based format | Scientific Literature | ||
5. | ALA5040296 | F | Antiviral activity against SARS-COV2 infected in A549 cells expressing ACE2 preincubated for 30 mins followed by cell addition after 48 hrs by Nano-glo luciferase reagent based assay | Severe acute respiratory syndrome coronavirus 2 | 1 | organism-based format | Scientific Literature | ||
6. | ALA5040297 | B | Binding affinity to biotinylated recombinant SARS-COV2 S-RBD by SPR analysis | Severe acute respiratory syndrome coronavirus 2 | 1 | single protein format | Scientific Literature |